MECOM and acute myeloid leukemia: Recently, GPR56 has been recognized as one of the highly expressed genes in refractory LSC9 and is a novel and stable cell surface marker for human LSCs in many types of refractory AML without high EVI1 expression and for the majority of AML samples16.